Zoetis Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones

2025.12.03 21:48

I'm PortAI, I can summarize articles.

Zoetis Inc. (ZTS) shares fell 1.50% to $122.57 on Wednesday, underperforming compared to competitors like Merck & Co. Inc. (MRK), which rose 1.23%. This marks the third consecutive day of losses for Zoetis, with the stock 32.60% below its 52-week high. Trading volume was 4.9 million, above the 50-day average of 4.0 million.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Zoetis Inc. (ZTS) shed 1.50% to $122.57 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.30% to 6,849.72 and the Dow Jones Industrial Average rising 0.86% to 47,882.90. This was the stock's third consecutive day of losses. Zoetis Inc. closed 32.60% short of its 52-week high of $181.85, which the company achieved on December 13th. The stock underperformed when compared to some of its competitors Wednesday, as Merck & Co. Inc. (MRK) rose 1.23% to $102.27 and IDEXX Laboratories Inc. (IDXX) fell 0.93% to $725.93. Trading volume (4.9 M) eclipsed its 50-day average volume of 4.0 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 3, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-03-25 1648ET